James L. Wilbur

James L. Wilbur

Former Chief Commercial Officerat10x Genomics· In proxies 2022–2023

Pay in FY2023-78% from the year before · 10x Genomics stock +53.6% the same year

James L. Wilbur was paid $1.9M in FY2023 (Dec), down 78%. 10x Genomics stock rose 53.6% that year.

Pay$100 in the stock at the end of FY21 → $38
Pay is from the Summary Compensation Table of each 10x Genomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. 10x GenomicsPublic company · 4 yr
    • Former Chief Commercial Officer2022 – Present · 4 yrStock in role -42%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?